RxDoctor Payments Data

Carlita Dobbie, NP

Nurse Practitioner · Dover, NHNPI 1538744362

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,713 of the $2,187 with a category attached, or 78.3%. 12 manufacturers reported payments, led by Johnson & Johnson at 32.3% of the total. Among nurse practitioner clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,187in general payments, 2019–2025

Across 44 payments — averaging $49.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$706
  • E.r. Squibb & Sons, L.L.C.$278
  • Amgen$247
  • Regeneron Healthcare Solutions, Inc.$221
  • Sanofi$174
  • Janssen Scientific Affairs, LLC$140
  • plus $421 from 6 others

What the payments were for

  • Food & beverage$1,71378%
  • Education$47422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,187 in reported general payments places this provider in the 95th percentile of 714 nurse practitioner providers in New Hampshire.

See all nurse practitioner providers in New Hampshire

Medicare billing

Part B allowed, 2024
$35,560
Medicare patients
196
Services billed
782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VtamaTapinarof13$16,694
Ketoconazole231$4,868
Clobetasol Propionate45$1,903
Triamcinolone Acetonide52$1,630
Metronidazole13$1,045
Clindamycin Phosphate23$876
Ciclopirox23$456
Fluocinolone Acetonide13$429
Hydrocortisone59$233
Doxycycline Hyclate12$201
Mupirocin19$114

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Dover

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →